Adductor Canal Block and IPACK Block vs. Isolated Adductor Canal Block for Post-Operative Analgesia Following HTO/DFO/TTO

Part of paid clinical trials in New York, New York.

Sponsor
NYU Langone Health
Study ID
NCT06952556
Phase
PHASE4
Status
Recruiting
Apply to this trial

Conditions

  • Analgesia

Eligibility Criteria

Sex
ALL
Age
18 Years - 75 Years
Healthy Volunteers
Not accepted

Interventions

  • ACB — DRUG
    15 mL of 0.25% Bupivacaine block of the saphenous nerve injected under ultrasound guidance via adductor canal.
  • IPACK block — DRUG
    IPACK block with 20 mL of 0.25% Bupivacaine injected into the Interspace between the Popliteal Artery and Capsule of the Knee

Study Details

A randomized, single-blind, single-center study measuring the effects of adductor canal block combined with IPACK infiltration compared to adductor canal block alone on post-operative pain and opioid consumption in patients undergoing high tibial osteotomy (HTO)/distal femoral osteotomy (DFO)/tibial tubercle osteotomy (TTO).

Key Dates

Start date
Apr 28, 2025
Status verified
Feb 2026
Primary completion
Apr 28, 2027
Completion
Jun 28, 2027

Study Design

Enrollment
100 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Adductor Canal Block (ACB) + IPACK Block
    Participants receive ACB with IPACK block.
  • Active Comparator: Isolated Adductor Canal Block
    Participants receive ACB only.

Primary Outcome Measure

Opioid Utilization for First 24 Hours Post-Surgery [ Time Frame: Up to Hour 24 Post-Procedure (Post-Operative Day 1 [POD 1]) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
NYU Langone HealthNew YorkNew York10016-

Find similar trials in New York, NY

By research site
NYU Langone Health· New York, NY

Related Studies